IgG4相关肺病一例:病例报告并文献复习
IgG4-Related Lung Disease: A Case Report and Literature Review
DOI: 10.12677/ACM.2022.12111438, PDF,   
作者: 何雪琨, 王志强, 丛金鹏, 王美华, 于文成:青岛大学附属医院,呼吸与危重症医学科,山东 青岛;陈云庆:青岛大学附属医院,病理科,山东 青岛
关键词: IgG4相关肺病电视胸腔镜肺癌病例报告IgG4-Associated Lung Disease Thoracoscopy Lung Cancer Case Report
摘要: 目的:IgG4相关疾病(IgG4-RD)的诊断是一项复杂的任务,需要考虑广泛的鉴别诊断。方法:回顾性分析1例胸部CT表现状似肿瘤的IgG4相关肺病(IgG4-RLD)患者的病史资料、临床表现、实验室检查结果及治疗转归,并进行文献复习。结果:患者为61岁女性,胸部CT发现多发磨玻璃影,无明显症状,既往体健,无烟酒史。入院前已行肿瘤、结核病影像学及血清学筛查,均为阴性。最终电视胸腔镜下切除的肺组织病理结果显示纤维组织增生伴淋巴细胞和浆细胞浸润,部分区域IgG4+/IgG+细胞比超过40%,符合IgG4相关肺病的诊断标准。给予激素治疗后,患者肺部磨玻璃影吸收明显。结论:IgG4-RLD模拟肺癌甚至二者共病的情况值得重视,临床医生应关注两者的鉴别诊断。
Abstract: Objective: Diagnostic of IgG4-related disease (IgG4-RD) is a complex task, as a broad spectrum of differential diagnoses needs to be considered. Methods: We reviewed a case of IgG4-associated lung disease (IgG4-RLD) with tumor-like chest CT findings, analyzing the medical history, clinical mani-festations, laboratory findings, and treatment outcome, and also carried out a literature review. Results: A 61-year-old female patient was found to have multiple ground-glass opacities on chest CT without fever, cough, hemoptysis, or weight loss. She was previously healthy and had no history of alcohol or smoking. Imaging and serological screening of tumors and tuberculosis were performed before admission and were all negative. The pathological findings of the resected lung specimen af-ter TV thoracoscopy showed fibrous tissue hyperplasia with high lymphocyte and plasma cell infil-tration and IgG4-positive/IgG-positive cell ratio of more than 40% in some areas, meeting the diag-nostic criteria of IgG4-RLD. After glucocorticoid was treated, the chest CT showed that ground-glass opacity in the right lung was significantly absorbed. Conclusion: IgG4-RLD mimicking lung cancer or even comorbidity deserves attention and clinicians should pay attention to the differential diagno-sis between the two.
文章引用:何雪琨, 王志强, 丛金鹏, 陈云庆, 王美华, 于文成. IgG4相关肺病一例:病例报告并文献复习[J]. 临床医学进展, 2022, 12(11): 9976-9982. https://doi.org/10.12677/ACM.2022.12111438

参考文献

[1] Kamisawa, T., Funata, N., Hayashi, Y., et al. (2003) A New Clinicopathological Entity of IgG4-Related Autoimmune Disease. Journal of Gastroenterology, 38, 982-984. [Google Scholar] [CrossRef] [PubMed]
[2] Inoue, D., Yoshida, K., Yoneda, N., et al. (2015) IgG4-Related Disease: Dataset of 235 Consecutive Patients. Medicine (Baltimore), 94, e680. [Google Scholar] [CrossRef
[3] Deshpande, V., Zen, Y., Chan, J.K., et al. (2012) Consensus Statement on the Pathology of IgG4-Related Disease. Modern Pathology, 25, 1181-1192. [Google Scholar] [CrossRef] [PubMed]
[4] Zen, Y., Inoue, D., Kitao, A., et al. (2009) IgG4-Related Lung and Pleural Disease: A Clinicopathologic Study of 21 Cases. American Journal of Surgical Pathology, 33, 1886-1893. [Google Scholar] [CrossRef
[5] Morales, A.T., Cignarella, A.G., Jabeen, I.S., et al. (2019) An Update on IgG4-Related Lung Disease. European Journal of Internal Medicine, 66, 18-24. [Google Scholar] [CrossRef] [PubMed]
[6] Carruthers, M.N., Khosroshahi, A., Augustin, T., et al. (2015) The Diagnostic Utility of Serum IgG4 Concentrations in IgG4-Related Disease. Annals of Rheumatic Diseases, 74, 14-18. [Google Scholar] [CrossRef] [PubMed]
[7] Wallace, Z.S., Naden, R.P., Chari, S., et al. (2020) The 2019 American College of Rheumatology/European League against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis & Rheumatology, 72, 7-19. [Google Scholar] [CrossRef] [PubMed]
[8] Corcoran, J.P., Culver, E.L., Anstey, R.M., et al. (2017) Thoracic Involve-ment in IgG4-Related Disease in a UK-Based Patient Cohort. Respiratory Medicine, 132, 117-121. [Google Scholar] [CrossRef] [PubMed]
[9] Saraya, T., Ohkuma, K., Fujiwara, M., Miyaoka, C., et al. (2017) Clinical Characterization of 52 Patients with Immunoglobulin G4-Related Disease in a Single Tertiary Center in Japan: Special Reference to Lung Disease in Thoracic High-Resolution Computed Tomography. Respiratory Medicine, 132, 62-67. [Google Scholar] [CrossRef] [PubMed]
[10] Kamisawa, T., Zen, Y., Pillai, S., et al. (2015) IgG4-Related Dis-ease. The Lancet, 385, 1460-1471. [Google Scholar] [CrossRef
[11] Clerc, A., Reynaud, Q., Durupt, S., et al. (2017) Elevated IgG4 Serum Levels in Patients with Cystic Fibrosis. PLOS ONE, 12, e0181888. [Google Scholar] [CrossRef] [PubMed]
[12] Ebbo, M., Grados, A., Bernit, E., et al. (2012) Pathologies As-sociated with Serum IgG4 Elevation. International Journal of Rheumatology, 2012, Article ID: 602809. [Google Scholar] [CrossRef] [PubMed]
[13] Koneczny, I. (2020) Update on IgG4-Mediated Autoimmune Diseases: New Insights and New Family Members. Autoimmunity Reviews, 19, Article ID: 102646. [Google Scholar] [CrossRef] [PubMed]
[14] Yu, T., Wu, Y., Liu, J., et al. (2022) The Risk of Malignancy in Patients with IgG4-Related Disease: A Systematic Review and Meta-Analysis. Arthritis Research & Therapy, 24, 14. [Google Scholar] [CrossRef] [PubMed]
[15] Yamamoto, M., Yajima, H., Takahashi, H., et al. (2015) Every-day Clinical Practice in IgG4-Related Dacryoadenitis and/or Sialadenitis: Results from the SMART Database. Modern Rheumatology, 25, 199-204. [Google Scholar] [CrossRef] [PubMed]
[16] Khan, M.L., Colby, T.V., Viggiano, R.W., et al. (2010) Treatment with Bortezomib of a Patient Having Hyper IgG4 Disease. Clinical Lymphoma Myeloma & Leukemia, 10, 217-219. [Google Scholar] [CrossRef
[17] Skorda, A., Sklirou, A.D., Sakellaropoulos, T., Gianniou, D.D., Kastritis, E., et al. (2019) Non-Lethal Proteasome Inhibition Activates Pro-Tumorigenic Pathways in Multiple My-eloma Cells. Journal of Cellular and Molecular Medicine, 23, 8010-8018. [Google Scholar] [CrossRef] [PubMed]
[18] Neubert, K., Meister, S., Moser, K., et al. (2008) The Proteasome Inhibi-tor Bortezomib Depletes Plasma Cells and Protects Mice with Lupus-Like Disease from Nephritis. Nature Medicine, 14, 748-755. [Google Scholar] [CrossRef] [PubMed]
[19] Chang, C.C., Aversa, G., Punnonen, J., et al. (1993) Brequinar So-dium, Mycophenolic Acid, and Cyclosporin A Inhibit Different Stages of IL-4- or IL-13-Induced Human IgG4 and IgE Production in Vitro. Annals of the New York Academy of Sciences, 696, 108-122. [Google Scholar] [CrossRef] [PubMed]
[20] Sun, X., Liu, H., Feng, R., et al. (2016) Biopsy-Proven IgG4-Related Lung Disease. BMC Pulmonary Medicine, 16, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[21] Betancur-Vsquez, L., Gonzalez-Hurtado, D., Arango-Isaza, D., et al. (2020) IgG4-Related Disease: Is Rituximab the Best Therapeutic Strategy for Cases Refractory to Conventional Ther-apy? Results of a Systematic Review. Reumatología Clínica (English Edition), 16, 195-202. [Google Scholar] [CrossRef
[22] Otani, K., Inoue, D., Itoh, T., et al. (2018) Transbronchial Lung Biopsy for the Diagnosis of IgG4-Related Lung Disease. Histopathology, 73, 49-58. [Google Scholar] [CrossRef] [PubMed]